ArticleCJC open2020

Canadian Real-World Experience of Using Sacubitril/Valsartan in Patients With Heart Failure With Reduced Ejection Fraction: Insight From the PARASAIL Study.

Haissam Haddad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.